Skip to content

SLeep and OPioid UsE in Patients Undergoing Total Knee Arthroplasty

SLeep and OPioid UsE in Patients Undergoing Total Knee Arthroplasty

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04247646
Acronym
SLOPE
Enrollment
120
Registered
2020-01-30
Start date
2020-10-01
Completion date
2028-12-31
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium, Opioid Use, Pain, Postoperative, Sleep

Brief summary

Prescription opioid misuse and its associated negative effects have become an epidemic in the United States, and post-operative opioid use contributes to this terrible problem. Alternative strategies to opioid prescribing are thus highly sought after in the post-operative setting. Importantly, sleep and pain have a bi-directional relationship, and inadequate or impaired sleep regularly occur following orthopedic operations. Melatonin is an endogenous sleep hormone that can be administered exogenously, and that has been shown to have some potential as an analgesic agent. Here, using the premise that melatonin may improve sleep and pain in the post-operative setting, the investigators propose a randomized clinical trial in 120 participants undergoing total knee arthroplasties. Patients will be randomized to receive either sublingual melatonin 5 mg or matched placebo starting on post-operative day (POD) 0 and through POD . The investigators will measure post-operative opioid usage as the primary outcome, and post-operative pain scores as a secondary outcome. The primary safety outcome will be sedation level, as measured by the Richmond Agitation Sedation Scale (RASS). Sleep will be measured objectively using wrist-worn actigraphy. Participants will be followed through POD 28, and will also have baseline data on sleep, pain, and cognition obtained prior to surgery.

Interventions

DIETARY_SUPPLEMENTMelatonin

Participants will take sublingual melatonin (or placebo) nightly for 29 doses after undergoing total knee replacement surgery.

DIETARY_SUPPLEMENTPlacebo

Participants will take sublingual melatonin (or placebo) nightly for 29 doses after undergoing total knee replacement surgery.

Sponsors

Scripps Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults age 18 years and older * Undergoing elective total knee arthroplasty (single knee)

Exclusion criteria

* Non-English speakers * Individuals with dementia * Patients with liver cirrhosis * Patients currently taking prescription sleep aids * Patients with long-term (greater than 3 months prior to surgery), chronic opioid use

Design outcomes

Primary

MeasureTime frameDescription
Opioid usePost-operative day 0 through post-operative day 28morphine milligram equivalents of opioid medications used by the participant

Secondary

MeasureTime frameDescription
Pain levelPost-operative day 0 through post-operative day 28Numerical pain scores reported by the patient following surgery using the Visual Analog Scale (Scale of 0-10, with 0 being no pain and 10 being the worst possible pain).
Other pain medicine usagePost-operative day 0 through post-operative day 28Usage of non-opioid analgesics used by the participant
Total daily sleep durationPost-operative day 0 through post-operative day 28Minutes of sleep obtained daily as measured by actigraphy
Nightly sleep durationPost-operative day 0 through post-operative day 28Minutes of sleep obtained nightly as measured by actigraphy
Sleep fragmentationPost-operative day 0 through post-operative day 28Mean/median length of the sleep bout during nightly sleep

Other

MeasureTime frameDescription
Change in sleep duration pre and post-operativelyPost-operative day 0 through post-operative day 28change in sleep duration (minutes) following surgery, using pre-operative sleep data as the comparator
Sedation levelsPost-operative day 0 through post-operative day 28Sedation levels, as measured by the Richmond Agitation Sedation Scale (RASS), during inpatient stay. RASS scores are measured on a scale of -5 to +5 with -5 equating to deeply sedated (deep coma) and +5 equating to extremely agitated/combative.
Subjective sleepPost-operative day 0 through post-operative day 28subjective sleep scores as measured by the Richards Campbell Sleep Questionnaire while inpatient. The Richards Campbell Sleep Questionnaire is a 5-item questionnaire scored on a visual, 100 milimeter scale where the participants marks or selects where they fell on the scale in response to the specific question. Scores are assigned from 0-100 based on where the participant's response lies, with a higher score indicating better sleep.
Delirium incidence in those with elevated obstructive sleep apnea riskPost-operative day 0 through post-operative day 28Delirium incidence in those with elevated OSA risk, based on the Berlin and STOP-BANG criteria
Delirium IncidencePost-operative day 0 through hospital dischargeRates of inpatient delirium as measured by the Confusion Assessment Method

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026